DT
MRNA icon

Diversified Trust’s Moderna MRNA Stock Holding History

Diversified Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,187
Closed -$496K – 1080
2025
Q3 		$496K Sell
19,187
-1,757
-8% -$49K 0.01% 638
2025
Q2 		$578K Buy
20,944
+7,300
+54% +$192K 0.01% 556
2025
Q1 		$387K Buy
+13,644
New +$484K 0.01% 647
2024
Q1 		– Sell
-4,487
Closed -$446K – 898
2023
Q4 		$446K Buy
+4,487
New +$377K 0.02% 533
2023
Q2 		– Sell
-2,343
Closed -$360K – 881
2023
Q1 		$360K Sell
2,343
-103
-4% -$17K 0.01% 570
2022
Q4 		$439K Sell
2,446
-439
-15% -$71.8K 0.02% 463
2022
Q3 		$341K Buy
2,885
+153
+6% +$23.2K 0.02% 502
2022
Q2 		$390K Sell
2,732
-157
-5% -$22.4K 0.02% 476
2022
Q1 		$498K Buy
2,889
+137
+5% +$23.1K 0.02% 451
2021
Q4 		$699K Sell
2,752
-16
-0.6% -$4.68K 0.02% 350
2021
Q3 		$1.06M Buy
2,768
+391
+16% +$144K 0.04% 214
2021
Q2 		$559K Sell
2,377
-51
-2% -$9.11K 0.02% 364
2021
Q1 		$318K Buy
2,428
+456
+23% +$66.1K 0.01% 517
2020
Q4 		$206K Buy
+1,972
New +$200K 0.01% 663

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Diversified Trust's MRNA Position: Q4 2025 in Review

Diversified Trust sold out of Moderna (MRNA) in Q4 2025, closing a stake of 19,187 shares — an estimated $496K sold.

Diversified Trust first reported a position in MRNA in Q4 2020 and held it in 14 quarters. The position peaked at $1.06M in Q3 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Diversified Trust reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Diversified Trust sold 19,187 Moderna shares in Q4 2025, an estimated $496K.
  • Diversified Trust first reported a position in Moderna in Q4 2020 and held it in 14 quarters.
  • Diversified Trust's Moderna position peaked at $1.06M in Q3 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Diversified Trust's 13F filing for Q4 2025, filed 9 Jan 2026.